Skip to main content

Elopag 20 mg ( Eltrombopag)

Introduction

Product verification is an important part of responsible medicine use. Before purchasing or using Elopag, patients, caregivers, pharmacists and healthcare professionals should confirm the product’s identity, strength, manufacturer, packaging information and supply source.

Elopag is listed as a brand of eltrombopag olamine in Bangladesh. The manufacturer’s product catalogue identifies Elopag 25 mg and Elopag 50 mg as eltrombopag products manufactured by Everest Pharmaceuticals Ltd.

However, an important strength discrepancy requires attention: the 20 mg strength previously associated with this website has not been verified in the manufacturer’s published Elopag product catalogue. The manufacturer’s listed strengths are 25 mg and 50 mg. A product labelled Elopag 20 mg should therefore not be presented as verified without additional manufacturer and regulatory documentation.

This page explains how to examine Elopag packaging, identify important product details, check manufacturer information and take appropriate action if a medicine appears suspicious.

1. Elopag Product Identity

Elopag is a brand associated with eltrombopag, a thrombopoietin receptor agonist used in selected patients with certain conditions involving low platelet counts.

The following information provides a preliminary product identity reference.

Product informationDetails
Brand nameElopag
Active ingredientEltrombopag
Salt form listed in medicine referencesEltrombopag olamine
Therapeutic categoryThrombopoietin receptor agonist
Dosage formTablet
Listed manufacturerEverest Pharmaceuticals Ltd.
Manufacturer-listed strengths25 mg and 50 mg
Country associated with manufacturerBangladesh
20 mg strengthNot verified in the manufacturer’s published catalogue

The information above identifies the manufacturer’s listed Elopag products. It does not independently authenticate an individual package or establish that every product carrying the Elopag name is genuine.

Before relying on the product information, compare it with the original packaging and applicable regulatory documentation.

2. Manufacturer Verification

Manufacturer identification is one of the most important parts of product verification.

The official product catalogue of Everest Pharmaceuticals Ltd. lists the following Elopag products:

  • Elopag 25 – Eltrombopag INN 25 mg.
  • Elopag 50 – Eltrombopag INN 50 mg.

The catalogue places these products under its hematology product category.

The manufacturer’s name and product identity should be checked against the actual carton, blister packaging and supplied prescribing information.

Manufacturer details to check

When examining an Elopag package, look for:

  • Manufacturer’s full legal name.
  • Manufacturing address, where printed.
  • Product brand name.
  • Active ingredient.
  • Tablet strength.
  • Batch or lot number.
  • Manufacturing date, where applicable.
  • Expiry date.
  • Product registration or authorization information, where applicable.
  • Patient information leaflet or prescribing information.

If any information is missing, unclear or inconsistent, ask a pharmacist or contact the manufacturer through independently verified contact information.

3. Important Verification of Elopag Strengths

Medicine strength is a critical part of product identification.

The manufacturer’s published product catalogue identifies Elopag in 25 mg and 50 mg strengths. These are also reflected in Bangladeshi medicine reference listings.

The 20 mg strength should not be assumed to be an established Elopag strength merely because it appears in a website title, product description or third-party advertisement.

Why strength verification matters

An incorrect strength description can create confusion during purchasing, dispensing and treatment.

For example:

  • A 20 mg tablet is not interchangeable with a 25 mg tablet solely because both contain eltrombopag.
  • A 50 mg tablet should not be treated as equivalent to a lower-strength tablet without a prescribed dosing calculation.
  • The strength printed on the original packaging should match the prescription and dispensing record.
  • A website listing cannot replace the manufacturer’s product documentation.

Verification notice: Before publishing or advertising Elopag 20 mg, obtain documentary confirmation from Everest Pharmaceuticals Ltd. and the relevant regulatory authority. Until then, this website should identify the 20 mg presentation as unverified.

4. How to Check Elopag Packaging

Carefully inspecting the medicine packaging can help identify missing or inconsistent information.

However, good-quality packaging alone does not prove that a medicine is genuine. Counterfeit products may imitate legitimate packaging.

Product name

Check that the brand name is clearly printed and matches the product supplied or prescribed.

Active ingredient

The packaging should identify the active ingredient as eltrombopag, using the exact terminology provided in the approved product information.

Strength

Confirm whether the package identifies Elopag 25 mg or Elopag 50 mg, or another strength supported by valid product documentation.

Do not rely on a seller’s description when the original package states something different.

Dosage form

Check the dosage form printed on the carton and blister. Manufacturer information identifies Elopag as a tablet product.

Manufacturer’s name

The manufacturer’s identity should be consistent with the applicable approved product documentation.

Batch or lot number

Look for the batch or lot number on the packaging. It is an important reference when contacting the manufacturer or reporting a suspected quality problem.

Manufacturing and expiry dates

Check the dates carefully. Do not use a product that is expired or whose date information appears altered or unreadable.

Packaging condition

Inspect the carton and blister for:

  • Unusual damage.
  • Broken seals.
  • Signs of tampering.
  • Missing printed information.
  • Poorly printed text.
  • Altered batch or expiry details.
  • Unusual differences between individual packaging components.

Any suspicious finding should be discussed with a pharmacist before the medicine is used.

5. How to Check the Batch Number

A batch number is a manufacturing identification code assigned to a particular production batch.

It helps manufacturers and regulatory authorities trace products during quality investigations, recalls and safety assessments.

When checking Elopag, compare the batch information printed on the outer carton with the information printed on the blister packaging, where applicable.

What to look for

  1. The batch number should be readable.
  2. The printed information should not appear deliberately altered.
  3. The carton and blister details should be consistent where batch information is repeated.
  4. The expiry date should be clearly identifiable.
  5. Any discrepancy should be investigated before use.

Does a batch number prove authenticity?

No. A printed batch number alone does not establish that a medicine is genuine.

Counterfeit medicines can carry copied or fabricated batch numbers. Confirmation should come from the manufacturer or an appropriate regulatory verification process.

6. QR Codes and Authentication Features

Some pharmaceutical products use QR codes, serial numbers, security labels or other authentication technologies.

However, a website should not claim that Elopag has a specific QR-code verification system, online authentication portal or serial-number service unless that system has been confirmed by the manufacturer or relevant regulatory authority.

If a package contains a QR code:

  • Check whether the manufacturer officially documents its purpose.
  • Use only an authentication process confirmed by the manufacturer.
  • Do not assume that a working QR code proves authenticity.
  • Report suspicious redirects or inconsistent product information.

A QR code can be copied or reproduced, so it should never be treated as the only verification method.

7. How to Identify Potentially Falsified Elopag

Falsified medicines are products that deliberately misrepresent their identity, composition or source.

They may contain the wrong ingredient, incorrect strength, insufficient active ingredient, harmful contaminants or no active ingredient at all.

Possible warning signs include:

  • Unexpected differences in the brand name.
  • Incorrect or inconsistent strength information.
  • Missing manufacturer details.
  • Altered batch numbers.
  • Expired products.
  • Broken or suspicious packaging.
  • Unusual tablet appearance.
  • Missing patient information.
  • Packaging that differs from manufacturer-confirmed examples.
  • Supply from an unverified seller.

These signs do not independently prove that a medicine is counterfeit, but they justify further investigation.

8. What to Do If Elopag Packaging Appears Suspicious

If you suspect that an Elopag product may be falsified, damaged or incorrectly labelled, take the following precautions.

Do not use the questionable product

Avoid taking tablets from packaging that appears altered, damaged or inconsistent until a pharmacist or appropriate authority has assessed the concern.

Keep the original packaging

Retain the carton, blister strips, leaflet and purchase documentation. These materials may help the manufacturer investigate the product.

Record the product details

Note the following information:

  • Brand name.
  • Stated strength.
  • Active ingredient.
  • Batch number.
  • Expiry date.
  • Manufacturer’s name.
  • Purchase location.
  • Date of purchase.

Contact a qualified pharmacist

Ask a pharmacist to examine the product and advise whether additional verification is required.

Contact the manufacturer

Request confirmation of the product identity and relevant batch information through independently verified manufacturer contact details.

Report suspected falsification

Where appropriate, report suspected falsified medicines to the relevant national medicines regulatory authority.

9. Why Buying Through Authorized Supply Channels Matters

The supply source is an important part of medicine safety.

Prescription medicines should be obtained through legitimate and appropriately authorized pharmaceutical supply channels.

Before purchasing Elopag, consider whether:

  • The supplier is appropriately licensed.
  • The medicine is supplied in its original packaging.
  • A valid prescription is required and available.
  • Product and batch information can be checked.
  • The supplier provides a proper purchase record.
  • The product can be traced to a legitimate supply chain.

Avoid purchasing prescription medicines from unknown sellers or sources that cannot provide reliable product information.

10. Regulatory Verification

Product registration and authorization requirements differ between countries.

A medicine marketed in one country should not automatically be assumed to have the same regulatory status in another country.

For Elopag, verification should consider:

  • The relevant national medicine registration.
  • The approved manufacturer.
  • The authorized product name.
  • Approved strengths.
  • Dosage form.
  • Approved prescribing information.
  • Applicable manufacturing and quality requirements.

In Bangladesh, relevant product authorization and regulatory information should be checked with the Directorate General of Drug Administration (DGDA).

A manufacturer’s catalogue can help identify a product, but it does not replace confirmation of its current regulatory authorization.

11. Product Verification Checklist

Before accepting or using an Elopag package, review the following information.

  • Brand name matches the supplied product.
  • Active ingredient is identified as eltrombopag.
  • Strength matches the prescription.
  • Dosage form matches the approved product information.
  • Manufacturer details are consistent.
  • Batch number is readable.
  • Expiry date is valid.
  • Packaging is intact.
  • Blister information is consistent with the carton.
  • Product leaflet is available where required.
  • Supply source is legitimate.
  • Regulatory information can be checked where applicable.

If any important detail is unclear, seek professional assistance before using the medicine.

12. Frequently Asked Questions About Elopag Product Verification

What is Elopag?

Elopag is a brand of eltrombopag listed in Bangladesh. Everest Pharmaceuticals Ltd. identifies Elopag 25 mg and Elopag 50 mg in its hematology product catalogue.

Who manufactures Elopag?

The published product information identifies Everest Pharmaceuticals Ltd. as the manufacturer of Elopag 25 mg and Elopag 50 mg.

Is Elopag 20 mg an officially verified strength?

The manufacturer’s published catalogue lists Elopag 25 mg and 50 mg. The 20 mg strength has not been verified through that catalogue and requires additional manufacturer and regulatory documentation.

What is the active ingredient in Elopag?

Elopag contains eltrombopag. Medicine references may identify the ingredient as eltrombopag olamine.

How can I check whether Elopag is genuine?

Inspect the original packaging, product name, strength, manufacturer, batch number and expiry date. For confirmation, contact the manufacturer or relevant regulatory authority.

Does a batch number prove that Elopag is authentic?

No. A batch number helps trace a medicine but can be copied or falsified. Manufacturer confirmation is more reliable.

Does Elopag have an official QR-code verification system?

A specific Elopag authentication system should not be assumed unless Everest Pharmaceuticals Ltd. confirms that it exists and explains how it works.

What should I do if the Elopag packaging is damaged?

Do not use a suspicious or potentially tampered product until it has been assessed by a pharmacist or another appropriate healthcare professional.

Can I verify Elopag through the manufacturer?

You can request product and batch verification from Everest Pharmaceuticals Ltd. using independently confirmed company contact details.

Why is product verification important?

Verification helps reduce the risk of using expired, incorrectly labelled, falsified or improperly supplied medicines. It also helps ensure that the medicine’s strength and identity match the prescribed treatment.

Important Safety Information

Elopag contains eltrombopag, a prescription medicine that requires appropriate medical supervision.

Eltrombopag can cause serious adverse reactions, including liver injury and thrombotic or thromboembolic complications. Platelet counts and liver function may need regular monitoring.

Do not start treatment, change the dose or substitute one strength for another based on website information. Follow the prescription and approved product leaflet.

If a medicine’s identity or authenticity is uncertain, consult a pharmacist and contact the manufacturer or relevant regulatory authority before using it.

References

  1. Everest Pharmaceuticals Ltd. – Official Hematology Product Catalogue, Elopag 25 and Elopag 50.
  2. MedEx Bangladesh – Eltrombopag Olamine: Available Brand Names and Product Information.
  3. Directorate General of Drug Administration (DGDA), Bangladesh – National medicine regulatory information.
  4. World Health Organization (WHO) – Information and guidance on substandard and falsified medical products.
  5. U.S. Food and Drug Administration (FDA) – PROMACTA (eltrombopag) Prescribing Information.

Final Verification Note: The information on this page does not authenticate any individual Elopag package. The manufacturer’s published catalogue identifies 25 mg and 50 mg strengths. The previously stated 20 mg presentation requires independent confirmation before it is described as an available or verified Elopag product.